PedAM
Pediatric Disease Annotations & Medicines
| Disease | pleural effusion disorder |
| Symptom | |lung cancer |
| Sentences | 63 |
| PubMedID- 25636447 | lung cancer patients with pleural effusion sb7-h4 levels below 35.8 ng/ml had a longer overall survival than those with higher levels (p < 0.05). |
| PubMedID- 25339042 | Prognostic values of vegf and endostatin with malignant pleural effusions in patients with lung cancer. |
| PubMedID- 25706291 | Clinical features and survival of lung cancer patients with pleural effusions. |
| PubMedID- 24183869 | Adaptive radiotherapy of lung cancer patients with pleural effusion or atelectasis. |
| PubMedID- 25346242 | Methods: the expressions of moc-31 and calretinin were detected by means of s-p immunocytochemical technique in pleural effusions of patients with lung cancer (n = 92) and in patients with benign lung disease (n = 70). |
| PubMedID- 24720371 | Aim: the aim of this study was to evaluate the diagnostic value of soluble receptor-binding cancer antigen expressed on siso cells (srcas1) and carcinoembryonic antigen (cea) in lung cancer patients with malignant pleural effusion (mpe) and benign pleural effusion (bpe). |
| PubMedID- 21625182 | Materials and methods: we analyzed f-18 fdg pet/ct images of 33 lung cancer patients with pleural effusion. |
| PubMedID- 24748865 | The cytological positivity of pleural effusion in lung cancer in the literature is 3.7–38.6% . |
| PubMedID- 21224698 | A case of lung cancer with malignant pleural effusion obtained a long-time survival after intra-operative hyperthermo-chemotherapy. |
| PubMedID- 23408789 | Their study showed that there were increased numbers of regulatory cd4+cd25+ t cells in malignant pleural effusion from patients with lung cancer compared with pleural lavage from patients with lung cancer without pleural effusion, and that these cells had constitutive high-level expression of foxp3 and cytotoxic lymphocyte-associated antigen-4. |
| PubMedID- 25473564 | Malignant pleural effusion typically occurs in patients with lung cancer, malignant mesothelioma, malignant lymphoma, genitourinary tract malignancies, or gastrointestinal tract malignancies. |
| PubMedID- 24872958 | provides functional evidence that regulatory t cells from malignant pleural effusion in lung cancer were found to inhibit generation and differentiation of th17 cells via the latency-associated peptide lap. |
| PubMedID- 25798278 | Response to bevacizumab combination chemotherapy of malignant pleural effusions associated with non-squamous non-small-cell lung cancer. |
Page: 1 2